Kate Priestman
Director/Board Member at OXFORD NANOPORE TECHNOLOGIES PLC
Net worth: 32 192 $ as of 30/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Adam Walker | M | 57 |
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GlaxoSmithKline Intellectual Property (No. The company is based in Middlesex, UK and engages in the development, enhancement, maintenance, protection, and exploitation of intellectual properties. 3) Ltd. is a subsidiary of GSK Plc.
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. An apprenticeship program is offered to students who want to start their GSK career from day one by learning from industry experts. GSK also provides advice to shareholders about how to be aware of share scams that typically come from overseas-based brokers. Explore the British company's social media channels and access their social media community guidelines. 4) Ltd. is a company founded in 2018 that unites science, technology, and talent to get ahead of disease.
GlaxoSmithKline Intellectual Property Management Ltd.
GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property Management Ltd. is a British biopharma company focused on unlocking the science of the immune system to understand how the body's defence system reacts to disease. The company is based in Brentford, UK. GSK offers a portfolio of brands and educational resources for patients and healthcare professionals. GSK has recently acquired TESARO, an oncology-focused company, and has launched a tracing programme in partnership with ProSearch to reunite lost shareholders with unclaimed entitlements.
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
GlaxoSmithKline Intellectual Property (No. 2) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. The British company combines human genetics, genomics, and advanced technologies to develop more effective vaccines and medicines. This privacy notice applies to any individual who is a current or former registered shareholder of GSK Plc. The company's purpose is to unite science, technology, and talent to get ahead of disease together. 2) Ltd. is a biopharma company founded in 2012.
Glaxosmithkline Intellectual Property Development Ltd.
Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British biopharma company founded in 2012. The company is based in Middlesex, UK. GlaxoSmithKline Intellectual Property Development unites science, technology, and talent to get ahead of disease together. The company recently completed a transaction to combine its consumer healthcare businesses into a new Joint Venture. | 11 years |
Jerome Charles Maurice Andries | M | 55 |
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
GlaxoSmithKline Intellectual Property (No. 2) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. The British company combines human genetics, genomics, and advanced technologies to develop more effective vaccines and medicines. This privacy notice applies to any individual who is a current or former registered shareholder of GSK Plc. The company's purpose is to unite science, technology, and talent to get ahead of disease together. 2) Ltd. is a biopharma company founded in 2012.
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. An apprenticeship program is offered to students who want to start their GSK career from day one by learning from industry experts. GSK also provides advice to shareholders about how to be aware of share scams that typically come from overseas-based brokers. Explore the British company's social media channels and access their social media community guidelines. 4) Ltd. is a company founded in 2018 that unites science, technology, and talent to get ahead of disease.
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GlaxoSmithKline Intellectual Property (No. The company is based in Middlesex, UK and engages in the development, enhancement, maintenance, protection, and exploitation of intellectual properties. 3) Ltd. is a subsidiary of GSK Plc.
GlaxoSmithKline Intellectual Property Management Ltd.
GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property Management Ltd. is a British biopharma company focused on unlocking the science of the immune system to understand how the body's defence system reacts to disease. The company is based in Brentford, UK. GSK offers a portfolio of brands and educational resources for patients and healthcare professionals. GSK has recently acquired TESARO, an oncology-focused company, and has launched a tracing programme in partnership with ProSearch to reunite lost shareholders with unclaimed entitlements.
Glaxosmithkline Intellectual Property Development Ltd.
Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British biopharma company founded in 2012. The company is based in Middlesex, UK. GlaxoSmithKline Intellectual Property Development unites science, technology, and talent to get ahead of disease together. The company recently completed a transaction to combine its consumer healthcare businesses into a new Joint Venture. | 7 years |
Timothy Cowper | M | - | 12 years | |
Gordon Sanghera | M | - | 19 years | |
John Schoellerman | M | - | 5 years | |
Brian McNamee | M | 68 | 6 years | |
Simon Dingemans | M | 61 |
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
GlaxoSmithKline Intellectual Property (No. 2) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. The British company combines human genetics, genomics, and advanced technologies to develop more effective vaccines and medicines. This privacy notice applies to any individual who is a current or former registered shareholder of GSK Plc. The company's purpose is to unite science, technology, and talent to get ahead of disease together. 2) Ltd. is a biopharma company founded in 2012.
Glaxosmithkline Intellectual Property Development Ltd.
Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British biopharma company founded in 2012. The company is based in Middlesex, UK. GlaxoSmithKline Intellectual Property Development unites science, technology, and talent to get ahead of disease together. The company recently completed a transaction to combine its consumer healthcare businesses into a new Joint Venture.
GlaxoSmithKline Intellectual Property Management Ltd.
GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Intellectual Property Management Ltd. is a British biopharma company focused on unlocking the science of the immune system to understand how the body's defence system reacts to disease. The company is based in Brentford, UK. GSK offers a portfolio of brands and educational resources for patients and healthcare professionals. GSK has recently acquired TESARO, an oncology-focused company, and has launched a tracing programme in partnership with ProSearch to reunite lost shareholders with unclaimed entitlements. | 12 years |
Paul McKenzie | M | 58 | 5 years | |
James WIllcocks | M | - | 19 years | |
Adrian Hennah | M | 66 | 3 years | |
Clive Brown | M | - | 16 years | |
James Russell Wheatcroft | M | 57 |
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. An apprenticeship program is offered to students who want to start their GSK career from day one by learning from industry experts. GSK also provides advice to shareholders about how to be aware of share scams that typically come from overseas-based brokers. Explore the British company's social media channels and access their social media community guidelines. 4) Ltd. is a company founded in 2018 that unites science, technology, and talent to get ahead of disease.
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GlaxoSmithKline Intellectual Property (No. The company is based in Middlesex, UK and engages in the development, enhancement, maintenance, protection, and exploitation of intellectual properties. 3) Ltd. is a subsidiary of GSK Plc. | 5 years |
Megan Clark | M | 66 | 8 years | |
Nicholas Keher | M | 42 | - | |
Guy Asher Harmelin | M | 45 | 4 years | |
Marie McDonald | F | 68 | 11 years | |
Andrew Cuthbertson | M | 70 | 27 years | |
Zoe McDougall | F | - | 16 years | |
Hannah Coote | F | - | 4 years | |
Alison Watkins | F | 61 | 3 years | |
Andrew Nash | M | - | 18 years | |
Duncan Maskell | M | 63 | 3 years | |
William Mezzanotte | M | 66 | 6 years | |
Carolyn Hewson | F | 69 | 5 years | |
Rhodri Davies | M | - | 13 years | |
Emma Alice Ide Stanton | F | 48 | 4 years | |
Sarah Flannigan | F | 51 |
Royal Botanical Gardens
| - |
Mark Hill | M | 62 | 4 years | |
Sarah Lapworth | F | - | 11 years | |
Christina Hickie | F | - | - | |
Jimmy Baker | M | - | - | |
Kristen Stoops | F | - | - | |
Sara Agee Le | M | - | 3 years | |
Howard Orman | M | - | - | |
Richard Compton | M | - | 8 years | |
Philip Watkins | M | - | 4 years | |
Lakmal Jayasinghe | M | - | 18 years | |
Ken Lim | M | 50 | 11 years | |
Kate Priestman | F | - | 1 years | |
Bill Campbell | M | 64 | 10 years | |
Jeffrey Ball | M | 56 | 5 years | |
Elizabeth Walker | F | 55 | 7 years | |
Johanna Elizabeth Martin Waterous | F | 67 |
Royal Botanical Gardens
| - |
Stephen Hester | M | 63 |
Royal Botanical Gardens
| - |
Ian Karet | M | 61 |
Royal Botanical Gardens
| - |
Jordan J. Herman | M | - | 3 years | |
Heather Elizabeth Preston | M | 58 | 1 years | |
Carol Archer | M | - |
Royal Botanical Gardens
| - |
Duncan Tatton-Brown | M | 59 | 2 years | |
Gregory Boss | M | 62 | 23 years | |
John O'Higgins | M | 59 | 5 years | |
Joy Carolyn Linton | F | 59 | 4 years | |
Bernard Ronchi | M | - | - | |
Fiona Mead | F | 55 | 6 years | |
John Milton | M | - | - | |
Mark Dehring | M | - | - | |
Michael Crawley | M | - |
Royal Botanical Gardens
| 13 years |
Nicholas Baird | M | - |
Royal Botanical Gardens
| - |
Dame Amelia Fawcett | F | 67 |
Royal Botanical Gardens
| - |
Val Gooding | F | 74 |
Royal Botanical Gardens
| - |
Sam Lewis | F | - | - | |
Sarah Fortune | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Wendy Becker | F | 58 | 3 years | |
Sarah Gordon-Wild | F | - | 8 years |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 40 | 62.50% |
Australia | 24 | 37.50% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kate Priestman
- Personal Network